Biallelic BCMA loss causes anti-BCMA CAR-T resistance in myeloma

(4:35)

Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma

(9:38)

Biallelic PRDM12 mutations in MiTES, C. Moss et al

(3:2)

PL2.4 - Biallelic ATG7 variants impair autophagy leading to neurological disease

(9:18)

Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function

(5:26)

Allelic vs Locus Heterogeneity

(57)

Genomic Imprinting

(2:22)

Visualizing allele-specific expression in single cells reveals epigenetic mosaicism

(6:55)

Genes vs Alleles

(1:26)

Biallelic - Medical Meaning and Pronunciation

(35)

Overcoming BCMA loss in myeloma cells

(1:40)

3.4 Loss of heterozygosity (LOH)

(7:29)

NRF2 and biallelic FH inactivation

(16:12)

Loss of m1acp3Ψ Ribosomal RNA Modification Is a Major Feature of Cancer

(10:37)

Loss or Gain - Tales from the Genome

(38)

Alleles and Genes

(8:7)

Evidence of LAMA5 Biallelic Truncating Variants Causing Infantile Nephrotic Syndrome | Journal club

(5:45)

Why Parents Matter (Epigenetically): Genomic Imprinting in Health and Disease

(59:9)

Loss of function and gain of function mutation | oncogenes and tumor suppressor genes

(9:50)

Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned

(59:47)